A new epicatechin glucopyranoside derivative from Styrax suberifolius.

  • PubMed
  • May 4, 2025
  • 0 Comments

A new epicatechin glucopyranoside derivative from Styrax suberifolius.

Autor: Liu, Bing-Lei; Hu, Xin; He, Hua-Liang; Qiu, Lin; Li, You-Zhi; Ding, Wen-Bing

Publication year: 2020

Natural product research

issn:1478-6427 1478-6419

doi: 10.1080/14786419.2019.1569011


Abstract:

A new derivative of epicatechin glucopyranoside, (2R,3R)-3,7,4′-trihydroxy-5,3′-dimethoxyflavan 7-O-β-d-glucopyranoside (1), together with three mononuclear phenolic acid esters, methyl orsellinate (2), ethyl orsellinate (3) and methyl β-orcinolcarboxylate (4) were isolated from the bark of Styrax suberifolius. The structures of 1-4 were determined on the basis of extensive analysis of NMR and MS spectra combined with chemical hydrolysis. The antifungal activities of the isolated compounds against three plant pathogenic fungi, Alternaria solani, Fusarium oxysporum and Phomopsis cytospore were evaluated using radial growth inhibition assay. Compounds 2, 3 and 4 exerted selective inhibitory activities against the tested fungi. Among of them, methyl β-orcinolcarboxylate (4) exhibited obvious inhibitory effect against P. cytospore, with an inhibition rate of 86.72% at 100 μg/ml.

Language: eng

Rights:

Pmid: 30732479

Tags: Magnetic Resonance Spectroscopy; Mass Spectrometry; Plant Extracts/chemistry; antifungal activity; Antifungal Agents/*isolation & purification/pharmacology; Fungi/drug effects; Alternaria/drug effects; Catechin/chemistry/*isolation & purification/pharmacology; epicatechin derivative; flavonoid glycoside; Fusarium/drug effects; Styrax suberifolius; Styrax/*chemistry

Link: https://pubmed.ncbi.nlm.nih.gov/30732479/

  • Related Posts

    “Radiotherapy’s Role in Promoting Tumor Metastasis”

    Recent research has shown that radiotherapy, while effective in targeting tumors, may also have a negative impact by promoting metastasis. The study found that radiation can induce the expression of…

    Patient-Specific Gene Editing Used to Treat Rare Genetic Disease

    Researchers have successfully used base editors to correct a genetic disease in a newborn. This treatment could save infants with a rare and deadly condition. Original Source: https://pubmed.ncbi.nlm.nih.gov/40373211/

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    • May 10, 2025
    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    • May 10, 2025
    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    • May 10, 2025
    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    • May 10, 2025
    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    • May 10, 2025
    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    How Microwaves Actually Work: A Scientific Breakdown

    • May 10, 2025
    How Microwaves Actually Work: A Scientific Breakdown